Accelerate Companies

Introduction

Since launching in 2018, we have supported 15 fledgling life-science companies. Each cohort brings with it a diverse set of skills, expertise and experience, but they all share a deep passion for their science or technology and a desire to make a difference to the lives of tomorrow’s patients. We keep in touch with all our cohort companies and are proud to continue to support and follow their progress.

Meet the Current Cohort

Our 2020/21 cohort, ArkVax, ConcR, Paediatric HealthTech and Stroma Biosciences bonded over Zoom during a programme which, due to the pandemic, had to be conducted primarily online. However, this didn’t dampen their enthusiasm or impede their progress. Discover what they thought of their experience of Accelerate@Babraham here.

Read more

Alumni

Meet the Alumni

Therapeutics is our thing…but over the last three years our cohort companies have also come to us with strong foundational ideas across the fields of diagnostics, medical devices, and machine learning and AI. In each case we’ve been able to support them with very specific expert and investor introductions as well as help them refine their thinking; enabling them to take their science and technology further - equipping them for success.

Meet the Alumni

}

Latest News & Insights

Since launching in 2018 we have supported 15 companies. To date, our alumni has raised a total investment of £12.5m and we proudly shout about their successes and achievements whenever and wherever we can!

Kalium Health announces funding from National Institute for Health Research

Kalium Health announces funding from National Institute for Health Research

Kalium Health Ltd, which is working to help millions of people living with kidney disease and related conditions to manage their health at home, today announces it has been awarded funding by the National Institute for Health Research (NIHR).

Read more

Welsh startup Antiverse raises $2m for antibody discovery toolkit

Welsh startup Antiverse raises $2m for antibody discovery toolkit

New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies.

Read more

The 25 Best Biotech Incubators Hatching Startup Stars in Europe

The 25 Best Biotech Incubators Hatching Startup Stars in Europe

Incubators can give biotech startups the boost they need to get off the ground. Accelerate@Babraham has made Labiotech's top 25 biotech incubators across Europe supporting the next generation of life science startups.

Read more